ABSTRACT:
Pantoprazole, a proton pump inhibitor, is utilized to treat various gastric ailments such as benign gastric ulcers, acute ulcers of the duodenum, and GERD (gastric reflux disease). The purpose of this study was to use the direct compression approach to generate and optimize pantoprazole floating tablets. Key excipients like HPMC K4M, cyclodextrin, sodium bicarbonate, citric acid, and microcrystalline cellulose were employed. Using a Rotary tablet punch machine, the components were sieved, combined, and compressed into tablets. Lubricants like talc and magnesium stearate were subsequently added. Preformulation examinations assessed drug/polymer interactions by FTIR analysis and confirmed suitable excipients. A number of parameters were assessed for the tablets, such as buoyancy, floating lag time, hardness, thickness, friability, weight fluctuation, percent assay, and in vitro dissolution. The outcomes were within reasonable bounds and performed well in comparing with commercialized formulations. Among the formulation code F1, F2, F4, F5, F7, and F8 demonstrated good floatation properties, while F1 and F4 exhibited moderate floatation. The findings suggest that the floating pantoprazole tablet formulation enhances gastric residence time and bioavailability, thereby increasing therapeutic efficacy.
Cite this article:
Omraje A. Jadhav, Rajendra K. Surawase. Formulation Development and Evaluation of Pantoprazole Floating Tablet by using 2 Level Factorial Design. Research Journal of Pharmaceutical Dosage Forms and Technology. 2025; 17(1):7-8. doi: 10.52711/0975-4377.2025.00002
Cite(Electronic):
Omraje A. Jadhav, Rajendra K. Surawase. Formulation Development and Evaluation of Pantoprazole Floating Tablet by using 2 Level Factorial Design. Research Journal of Pharmaceutical Dosage Forms and Technology. 2025; 17(1):7-8. doi: 10.52711/0975-4377.2025.00002 Available on: https://rjpdft.com/AbstractView.aspx?PID=2025-17-1-2
REFERENCES:
1. Bagherwal A, Patidar DK, Sharma P. Formulation and evaluation of floating tablets of ciprofloxacin hydrochloride. Int J Comp Pharma 2010; 1: 1-4.
2. Kumar R. Development and in-vitro evaluation of sustained release floating matrix tablets of metformin hydrochloride. Int J Pharm Sci Res 2010; 1: 96-101.
3. Chodavarapu NP, Yendluri RB, Suryadevara H, Reddy P, Chhatoi P. Formulation and evaluation of abelmoschusesculentus mucilagebased metformin hydrochloride floating matrix tablets. Int J Pharm Tech. 2011; 3: 2725-45.
4. Kshirsagar RV, Jain V, Wattamwar S. Effect of different viscocity grade HPMC polymer on gastroretantive drug delivery of metformin hydrochloride. Int J Appl Pharm 2009; 1: 44-50.
5. Sahu G, Thakur A, Sahu D, Nagori K, Roy A, Kaur K, Shrivastava RK, Patel A, Niyazi A, Sharma M, Jain V. Development and evaluation of Pantoprazole sodium gastro retentive floating tablet. Neuro Quantology. 2022; 20(13): 1649.
6. Li CL, Martini LG, Ford JL, Roberts M. The use of hypromellose in oral drug delivery. Journal of Pharmacy and Pharmacology. 2005; May; 57(5): 533-46. https://doi.org/10.1211/0022357055957
7. Bharat W. Tekade, Umesh T. Jadhao, Pankaj H. Bari *, Dipali G. Chaudhary. Vijay. R. Patil. Formulation and evaluation of pantoprazole floating tablet by using natural gum J. Pharm. Sci. Innov. 2017; 6(4). https://doi.org/10.7897/2277-4572.06460
8. Arun D, VenuGopal N, Shekar L, Ramarao B. A review of novel approach in bilayer tablet technology. International Journal of Pharmaceutical, Biological and Chemical Sciences. 2012; Apr; 1(1): 1-8.
9. Indian Pharmacopoeia. Delhi: The controller of Publications. 1996; (1).
10. Wade A, Weller P. Handbook of pharmaceutical excipients. London: Pharmaceutical press 1994; 4: 151-52.
11. Arora S, Ali J, Ahuja A, Khar RK, Baboota S. Floating drug delivery systems: a review. Aaps PharmSciTech. 2005; Sep; 6: E372-90.
12. Sarambi PS, Sonawane A, Malipati SM, spectropphotometric estimataion of Ganciclovir in bulk drug and its formulation. INT.J. of pharm. Tch res. 2010; 2920: 1264-1268.
13. Sandip BS, Mahesh BN, Gautam DM, Prasad VR, Amit MP. Formulation and evaluation of gastroretentive floating tablets of acyclovir. World J. of pharmacy and pharm. Sci. 2012; 1(4): 140214012.
14. Disckon RB, Rajeshbhai TH, Sureshkumar P, Jamsheer AKK, Senthil A. formulations and evaluation of gastroretentive floating tablets of Glipizide. INT.J. of Res. In ayurveda and Pharmacy. 2011; 2930: 9111-917.
15. Sarangapani S, RajappanM, Lansoprazole from a floating dosage form based on the natural polymer of declonix regia, Int.j. of pharm. Tech. and Res 2012; 4(3): 1084-1095.
16. Dhiman S, Sing TG, design and optimization of floating matrix tablets of famontidine by central composite design Asian J, of Pharm and Clinical Res. 2012; 5(1); 45-49.
17. Jagadale SC, Agavelakr AJ, Pandya SV, Kuchalkar BS, Chabuksawar AR, formulation and evaluation of gastroretentive drug delivery system of Propranolol Hydrochloride. 2009; 10(3):1071-1079. https://doi.org/10.1208/s12249-009-9300-8
18. Bhoi P, Dsh RK, Dalai MK, formulation and evaluation of matrix tablets of Diclofenac sodium. Int.j. of pharm. tech res. 2010; 2(4): 2420-2428.
19. Zanke AA, Gangurde HH, Ghonge AB, Chavan PS. Recent advance in gastroretantive drug delivery system (GRDDS). Asian Journal of Pharmaceutical Research. 2022; 12(2): 143-9.